Patents by Inventor Claudine Kieda

Claudine Kieda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CELL-BASED GENE THERAPY FOR NEURODEGENERATIVE DISEASES
    Publication number: 20230248780
    Abstract: The present invention relates, in part, to cell-based gene therapies, including those targeting, by way of non-limiting example, TDP43 and A? aggregates, for the use in neurodegenerative disorders, including without limitation Amyotrophic Lateral Sclerosis (ALS) and Alzheimer's Disease, respectively.
    Type: Application
    Filed: October 14, 2022
    Publication date: August 10, 2023
    Inventors: Claude NICOLAU, Claudine KIEDA, Reynald THINARD, Ruth GREFERATH, Melanie CHEVALIER
  • CELL-BASED GENE THERAPY FOR NEURODEGENERATIVE DISEASES
    Publication number: 20220000935
    Abstract: The present invention relates, in part, to cell-based gene therapies, including those targeting, by way of non-limiting example, TDP43 and A? aggregates, for the use in neurodegenerative disorders, including without limitation Amyotrophic Lateral Sclerosis (ALS) and Alzheimer's Disease, respectively.
    Type: Application
    Filed: November 6, 2019
    Publication date: January 6, 2022
    Inventors: Claude NICOLAU, Claudine KIEDA, Reynald THINARD, Ruth GREFERATH, Melanie CHEVALIER
  • INOSITOL-BASED IMMUNOTHERAPIES
    Publication number: 20210361680
    Abstract: The present invention provides, inter alia, methods and compositions that are useful in the treatment of cancer.
    Type: Application
    Filed: May 3, 2019
    Publication date: November 25, 2021
    Inventors: Claude NICOLAU, Claudine KIEDA, Jean-Marie LEHN
  • Human and murine stem-cell lines: models of endothelial cell precursors
    Patent number: 9631178
    Abstract: The present invention relates to isolated human cells that are precursors of endothelial cells other than embryonic stem cells, to isolated murine cells that are precursors of endothelial cells, and to methods using same. In particular, the present invention relates to established cell lines of isolated human cells that are precursors of endothelial cells other than embryonic stem cells and established cell lines of isolated murine cells that are precursors of endothelial cells. The present invention can be used in particular in the medical and/or veterinary fields, in particular in the field of therapeutics and/or in the field of studies of cellular mechanisms.
    Type: Grant
    Filed: January 11, 2011
    Date of Patent: April 25, 2017
    Assignees: Centre National de la Recherche Scientifique—CNRS, Ludwick Hirszfeld Institute of Immunology and Experimental Therapy Polish Academy
    Inventors: Claudine Kieda, Catherine Grillon, Nathalie Lamerant-Fayel, Maria Paprocka, Agnieszka Krawczenko, Danuta Goszyk-Dus
  • METHOD OF REDUCING MULTI-DRUG RESISTANCE USING INOSITOL TRIPYROPHOSPHATE
    Publication number: 20160235771
    Abstract: Inositol trisphosphate (ITPP) causes normalization of tumor vasculature and is a particularly effective cancer therapy when a second chemotherapeutic agent is administered following partial vascularization. ITPP also treats, alone or in combination, multi-drug resistant cancers. ITPP can also be used to reduce the amount of a second chemotherapeutic drug required for anticancer activity. In addition, ITPP enhances immune response and treats hyperproliferative disorders.
    Type: Application
    Filed: May 3, 2016
    Publication date: August 18, 2016
    Inventors: Yves Claude Nicolau, Jean-Marie Lehn, Claudine Kieda
  • Organ-specific feline endothelial cells and uses thereof
    Patent number: 9228173
    Abstract: The present invention relates to isolated organ-specific feline endothelial cells. Specifically, the present invention relates to established organ-specific feline endothelial cells. The present invention also relates to organ-specific feline endothelial cells derived from micro- and macro-vascularisation. The present invention also relates to methods for screening molecules, for studying pathologies and for producing pathogens using same.
    Type: Grant
    Filed: January 11, 2011
    Date of Patent: January 5, 2016
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE—CNRS, ECOLE NATIONALE VETERINAIRE D'ALFORT
    Inventors: Claudine Kieda, Maria Paprocka, Michele Mitterand, Nathalie Lamerant-Fayel, Henri-Jean Boulouis, Nadia Haddad, Martine Monteil
  • METHOD OF REDUCING MULTI-DRUG RESISTANCE USING INOSITOL TRIPYROPHOSPHATE
    Publication number: 20140199261
    Abstract: Inositol trisphosphate (ITPP) causes normalization of tumor vasculature and is a particularly effective cancer therapy when a second chemotherapeutic agent is administered following partial vascularization. ITPP also treats, alone or in combination, multi-drug resistant cancers. ITPP can also be used to reduce the amount of a second chemotherapeutic drug required for anticancer activity. In addition, ITPP enhances immune response and treats hyperproliferative disorders.
    Type: Application
    Filed: July 25, 2013
    Publication date: July 17, 2014
    Applicants: Universite de Strasbourg, NormOxys, Inc.
    Inventors: Yves Claude Nicolau, Jean-Marie Lehn, Claudine Kieda
  • HUMAN AND MURINE STEM-CELL LINES: MODELS OF ENDOTHELIAL CELL PRECURSORS
    Publication number: 20130040315
    Abstract: The present invention relates to isolated human cells that are precursors of endothelial cells other than embryonic stem cells, to isolated murine cells that are precursors of endothelial cells, and to methods using same, In particular, the present invention relates to established cell lines of isolated human cells that are precursors of endothelial cells other than embryonic stem cells and established cell lines of isolated murine cells that are precursors of endothelial cells. The present invention can be used in particular in the medical and/or veterinary fields, in particular in the field of therapeutics and/or in the field of studies of cellular mechanisms.
    Type: Application
    Filed: January 11, 2011
    Publication date: February 14, 2013
    Applicant: Centre National De La Recherche Scientifique -CNRS-
    Inventors: Claudine Kieda, Catherine Grillon, Nathalie Lamerant-Fayel, Maria Paprocka, Agnieszka Krawczenko, Danura Goszyk-Dus
  • ORGAN-SPECIFIC FELINE ENDOTHELIAL CELLS AND USES THEREOF
    Publication number: 20130017547
    Abstract: The present invention relates to isolated organ-specific feline endothelial cells. Specifically, the present invention relates to established organ-specific feline endothelial cells. The present invention also relates to organ-specific feline endothelial cells derived from micro- and macro-vascularisation. The present invention also relates to methods for screening molecules, for studying pathologies and for producing pathogens using same.
    Type: Application
    Filed: January 11, 2011
    Publication date: January 17, 2013
    Applicants: ECOLE NATIONALE VETERINAIRE D'ALFORT, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFQUE - CNRS
    Inventors: Claudine Kieda, Maria Paprocka, Michele Mitterand, Nathalie Lamerant-Fayel, Henri-Jean Boulouis, Nadia Haddad, Martine Monteil
  • METHOD OF REDUCING MULTI-DRUG RESISTANCE USING INOSITOL TRIPYROPHOSPHATE
    Publication number: 20120003327
    Abstract: Inositol trisphosphate (ITPP) causes normalization of tumor vasculature and is a particularly effective cancer therapy when a second chemotherapeutic agent is administered following partial vascularization. ITPP also treats, alone or in combination, multi-drug resistant cancers. ITPP can also be used to reduce the amount of a second chemotherapeutic drug required for anticancer activity. In addition, ITPP enhances immune response and treats hyperproliferative disorders.
    Type: Application
    Filed: February 23, 2011
    Publication date: January 5, 2012
    Inventors: Yves Claude NICOLAU, Jean-Marie LEHN, Claudine KIEDA
  • Liposomal product with a ligand having fucose as a terminal moiety
    Patent number: 5686103
    Abstract: The invention concerns a method of binding a product to the membrane of a melanocyte by means of a ligand-receptor bond, which comprises using a product consisting of a basic structure coupled to at least one ligand consisting of an oside residue accessible to the membrane receptors, said oside residue being a fucose residue, notably an Alpha-L-fucose residue.
    Type: Grant
    Filed: September 23, 1996
    Date of Patent: November 11, 1997
    Assignee: Parfums Christian Dior
    Inventors: Gerard Redziniak, Dominique Cerdan, Claudine Kieda, Michel Monsigny
  • Method of targeting melanocytes with a compound containing a fucose residue
    Patent number: 5332575
    Abstract: The invention concerns a method of binding a product to the membrane of a melanocyte by means of a ligand-receptor bond, which comprises using a product consisting of a basic structure coupled to at least one ligand consisting of an oside residue accessible to the membrane receptors, said oside residue being a fucose residue, notably an Alpha-L-fucose residue.
    Type: Grant
    Filed: April 2, 1992
    Date of Patent: July 26, 1994
    Assignee: Parfums Christian Dior
    Inventors: Gerard Redziniak, Dominique Cerdan, Claudine Kieda, Michel Monsigny
  • Method of binding a product to the membrane of a keratinocyte by means of a ligand-receptor bond, method of preparing such a product, product obtained, cosmetic or pharmaceutical composition in which it is present and its method of preparation
    Patent number: 5286629
    Abstract: The invention relates to products which are to be bound specifically to the membrane of a keratinocyte by means of a ligand-receptor bond.These products carry at least one ligand consisting of an oside residue selected from .alpha.-L-rhamnose, .alpha.-D-galactose and .alpha.-D-galactose-6-phosphate.By virtue of this specificity, it is possible to prepare cosmetic or pharmaceutical compositions having an improved efficacy in particular, for example for regeneration of the epidermis, for the treatment of psoriasis or for renewed hair growth.
    Type: Grant
    Filed: November 4, 1991
    Date of Patent: February 15, 1994
    Assignee: Parfums Christian Dior
    Inventors: Alain Denis, Claudine Kieda, Michel Monsigny, Pierre Perrier, Gerard Redziniak